Progress in the development of small molecule therapeutics targeting Th17 cell function for the treatment of immune-inflammatory diseases. Shuttleworth S, Townsend P, Silva F, Cecil A, Hill T, Tomassi C, Rogers H, Harrison R. Prog Med Chem. 2011, 50, p109-33.
Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases. Shuttleworth SJ, Bailey SG, Townsend PA. Curr Drug Targets. 2010, 11(11), p1430-8.
Progress in the design and development of phosphoinositide 3-kinase (PI3K) inhibitors for the treatment of chronic diseases. Shuttleworth S, Silva F, Tomassi C, Cecil A, Hill T, Rogers H, Townsend P. Prog Med Chem. 2009, 48, p81-131.